compound or a pharmaceutically acceptable in vivo hydrolysable salt or ester thereof, pharmaceutical composition, method for treating mycobacterium tuberculosis, and process for the preparation of a compound or a pharmaceutically acceptable in vivo hydrolysable salt or ester thereof

摘要

COMPOSITE OR ITS SALT OR A PHARMACEUTICALLY ACCEPTABLE IN VIVO HYDROLISABLE ESTER, PHARMACEUTICAL COMPOSITION, METHOD FOR THE TREATMENT OF MYCOBACTERIUM TUBERCULOSIS, AND PROCESS FOR THE PREPARATION OF A COMPOUND OR A HISHAVABLE SALT. Compounds of formula (I) and their pharmaceutically acceptable in vivo hydrolyzable salts or esters, useful in the treatment of Mycobacterium tuberculosis (M.tb).